January 08, 2025 09:14 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Sheesh Mahal row: AAP leaders who were denied entry into CM's residence turn towards PM's house | Anna University sexual assault accused is a DMK supporter, not member: MK Stalin | Ajit Doval, Raja Dato discuss bilateral cooperation during India-Malaysia Security Dialogue | US President-elect Donald Trump threatens to use economic force to make Canada 51st US State, Justin Trudeau retorts sharply | Elon Musk raises concern on 'world population decline' including that of India, China | Indian-origin Anita Ananda might replace Justin Trudeau as Canadian PM | 'I won't bite': Kamala Harris tells Senator's husband as he refuses to shake hands with her | Centre announces memorial for Pranab Mukherjee, his daughter thanks PM Modi for 'gracious gesture' | Delhi assembly elections on Feb 5, results on Feb 8 | Allu Arjun visits boy injured during Pushpa 2 stampede in Hyderabad
Pfizer offers 5 cr Covid19 vaccine doses to India with conditions as External Affairs Minister S Jaishankar tours US

Pfizer offers 5 cr Covid19 vaccine doses to India with conditions as External Affairs Minister S Jaishankar tours US

May 26, 2021, at 05:44 am

New Delhi/IBNS: Pfizer has offered 5 crore Covid-19 vaccine doses to India albeit with pre-conditions as the country ramps up production amid a raging pandemic.

Indian govt, Pfizer hit deadlock over issue of legal protection on vaccine side effects: Report

Indian govt, Pfizer hit deadlock over issue of legal protection on vaccine side effects: Report

May 22, 2021, at 05:03 am

New Delhi/IBNS: US drug major Pfizer's coronavirus vaccine is facing hurdles in entering the Indian market over demand for legal protection from any adverse effects that may follow after the use of its jabs, a Reuters report said, citing sources.